Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCARB1 | Q8WTV0 | 1/20 | 0.34 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.34 |
| ▸ | USP14 | P54578 | 1/20 | 0.34 |
| ▸ | TDP2 | O95551 | 6/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.31 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.31 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.31 |
| ▸ | MAT2A | P31153 | 1/20 | 0.31 |
| ▸ | GRM5 | P41594 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22563701 | 0.95 | ABCG2 (0.36) | SCARB1ABCG2TDP2FFAR1CYP1A2 | |
| SCHEMBL22563696 | 0.91 | SCARB1 (0.35) | SCARB1ABCG2USP14TDP2FFAR1 | |
| SCHEMBL22563535 | 0.91 | CHEK1 (0.39) | ABCG2FFAR1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL21108305 | 0.90 | CRHR1 (0.33) | SCARB1USP14TDP2CYP1A2CYP2C9 | |
| SCHEMBL22563536 | 0.90 | STS (0.34) | SCARB1ABCG2CYP11B1CYP11B2GRM5 | |
| SCHEMBL22563464 | 0.89 | ALDH1A1 (0.34) | USP14CYP1A2CYP2C9CYP2C19NPSR1 | |
| SCHEMBL22563693 | 0.88 | ABCG2 (0.36) | SCARB1ABCG2TDP2FFAR1MAT2A | |
| SCHEMBL19919629 | 0.88 | CYP11B2 (0.35) | SCARB1USP14TDP2CYP1A2CYP2C9 | |
| SCHEMBL22563466 | 0.87 | IRAK4 (0.33) | — | |
| SCHEMBL23487291 | 0.87 | ABCG2 (0.37) | ABCG2USP14FFAR1CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210175434-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210175434-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, OR51E2, OCIAD2 | SCARB1 3130/4885ABCG2 2612/4885USP14 4155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.